Cite
Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication
MLA
Chenyang Xiang, et al. “Biomimetic Carbon Nanotubes for Neurological Disease Therapeutics as Inherent Medication.” Acta Pharmaceutica Sinica B, vol. 10, no. 2, Feb. 2020, pp. 239–48. EBSCOhost, https://doi.org/10.1016/j.apsb.2019.11.003.
APA
Chenyang Xiang, Yuxuan Zhang, Weisheng Guo, & Xing-Jie Liang. (2020). Biomimetic carbon nanotubes for neurological disease therapeutics as inherent medication. Acta Pharmaceutica Sinica B, 10(2), 239–248. https://doi.org/10.1016/j.apsb.2019.11.003
Chicago
Chenyang Xiang, Yuxuan Zhang, Weisheng Guo, and Xing-Jie Liang. 2020. “Biomimetic Carbon Nanotubes for Neurological Disease Therapeutics as Inherent Medication.” Acta Pharmaceutica Sinica B 10 (2): 239–48. doi:10.1016/j.apsb.2019.11.003.